Olema Pharmaceuticals, Inc. Common Stock (OLMA) is a publicly traded Healthcare sector company. As of September 14, 2026, OLMA trades at $9.13 with a market cap of $894.23M and a P/E ratio of -4.72. OLMA moved -10.71% today. Year to date, OLMA is -59.23%; over the trailing twelve months it is +27.75%. Its 52-week range spans $2.86 to $36.26. Analyst consensus is strong buy with an average price target of $37.50. Rallies surfaces OLMA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for OLMA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $9.13 |
| Market Cap | $894.23M |
| P/E Ratio | -4.72 |
| EPS | $-1.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $36.26 |
| 52-Week Low | $2.86 |
| Volume | 19.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-162.45M |
| Gross Margin | 0.00% |
7 analysts cover OLMA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $37.50.